Clinical Trial Update: TP0502-B-Pharmaco-Scintigraphic-Study [Phase 1]

View source ↗

Summary

A Phase 1 pharmaco-scintigraphic study of TP0502-B for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TP0502-B

Snippet

Sponsor: Tillotts Pharma AG | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED